PT  - JOURNAL ARTICLE
AU  - Yassi, Annalee
AU  - Barker, Stephen
AU  - Lockhart, Karen
AU  - Grant, Jennifer M.
AU  - Okpani, Arnold Ikedichi
AU  - Sprague, Stacy
AU  - Zungu, Muzimkhulu
AU  - Lubin, Stan
AU  - Sing, Chad Kim
TI  - Healthcare worker risk of COVID-19: A 20-month analysis of protective measures from vaccination and beyond
AID  - 10.1101/2021.12.02.21267190
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.02.21267190
4099  - http://medrxiv.org/content/early/2021/12/05/2021.12.02.21267190.short
4100  - http://medrxiv.org/content/early/2021/12/05/2021.12.02.21267190.full
AB  - Background As the COVID-19 pandemic continues and new variants such as Omicron emerge, we aimed to re-evaluate vaccine effectiveness as well as impacts of rigorously implemented infection control, public health and occupational health measures in protecting healthcare workers (HCWs).Methods Following a cohort of 21,242 HCWs in Vancouver, British Columbia, Canada, for 20 months since the pandemic started, we used Cox regression and test-negative-design to examine differences in SARS-COV-2 infection rates compared to community counterparts, and within the HCW workforce, assessing the role of occupation, testing accessibility, vaccination rates, and vaccine effectiveness over time.Results Nurses, allied health professionals and medical staff in this jurisdiction had a significantly lower rate of infection compared to their age-group community counterparts, at 47.4, 41.8, and 55.3% reduction respectively; controlling for vaccine-attributable reductions, the protective impact was still substantial, at 33.4, 28.0, and 36.5% respectively. Licensed practical nurses and care aides had the highest risk of infection among HCWs, more than double that of medical staff. However, even considering differences in vaccination rates, no increase in SARS-CoV-2 infection was found compared to community rates, with combined protective measures beyond vaccination associated with a 17.7% reduced SARS-COV-2 rate in the VCH workforce overall. There was also no evidence of waning immunity within at least 200 days after second dose.Conclusion Rigorously implemented occupational health, public health and infection control measures results in a well-protected healthcare workforce with infection rates at or below rates in community counterparts. Greater accessibility of vaccination worldwide is essential; however, as implementing measures to protect this workforce globally also requires considerable health system strengthening in many jurisdictions, we caution against overly focusing on vaccination to the exclusion of other crucial elements for wider protection of HCWs, especially in facing ongoing mutations which may escape current vaccines.Health and care workers are the foundation of health systems and the driving force to achieving universal health coverage and global health security. …However, too many of them have become infected, ill or died as a result of COVID-19…. These deaths are a tragic loss. They are also an irreplaceable gap in the world’s pandemic response…the world cannot be complacent.World Health Organization Steering Committee for the International Year of Health and Care Workers in 2021 (1)Competing Interest StatementAY, JG, SS, CKS, SL and AO are staff or contractors of Vancouver Coastal Health. AO, KL and SB are paid on grant funds. AY is partially paid from a research chair through the Canadian government.Funding StatementThis work was supported by The International Development Research Centre (IDRC) under grant M20‐ 00559, Protecting healthcare workers from COVID‐ 19: a comparative contextualized analysis. AY is supported as a Chair in Global Health from the Canada Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the University of British Columbia (H21-01138).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying the results presented in the study are available at http://innovation.ghrp.ubc.ca/COVID19/data-2021.11.29.xlsx http://innovation.ghrp.ubc.ca/COVID19/data-2021.11.29.xlsx